BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 16208418)

  • 1. A replication competent lentivirus (RCL) assay for equine infectious anaemia virus (EIAV)-based lentiviral vectors.
    Miskin J; Chipchase D; Rohll J; Beard G; Wardell T; Angell D; Roehl H; Jolly D; Kingsman S; Mitrophanous K
    Gene Ther; 2006 Feb; 13(3):196-205. PubMed ID: 16208418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel bovine lentiviral vectors based on Jembrana disease virus.
    Metharom P; Takyar S; Xia HH; Ellem KA; Macmillan J; Shepherd RW; Wilcox GE; Wei MQ
    J Gene Med; 2000; 2(3):176-85. PubMed ID: 10894263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of HIV- and EIAV-based vectors on their efficiency in transducing murine and human hematopoietic repopulating cells.
    Siapati EK; Bigger BW; Miskin J; Chipchase D; Parsley KL; Mitrophanous K; Themis M; Thrasher AJ; Bonnet D
    Mol Ther; 2005 Sep; 12(3):537-46. PubMed ID: 16099415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an equine-tropic replication-competent lentivirus assay for equine infectious anemia virus-based lentiviral vectors.
    Farley DC; Bannister R; Leroux-Carlucci MA; Evans NE; Miskin JE; Mitrophanous KA
    Hum Gene Ther Methods; 2012 Oct; 23(5):309-23. PubMed ID: 23121195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of inducible EIAV-based lentiviral vector packaging and producer cell lines.
    Stewart HJ; Leroux-Carlucci MA; Sion CJ; Mitrophanous KA; Radcliffe PA
    Gene Ther; 2009 Jun; 16(6):805-14. PubMed ID: 19262613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.
    Yamada K; Olsen JC; Patel M; Rao KW; Walsh CE
    Mol Ther; 2001 Apr; 3(4):485-90. PubMed ID: 11319908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
    Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
    J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene transfer vectors derived from equine infectious anemia virus.
    Olsen JC
    Gene Ther; 1998 Nov; 5(11):1481-7. PubMed ID: 9930301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of replication competent retrovirus and lentivirus.
    Sastry L; Cornetta K
    Methods Mol Biol; 2009; 506():243-63. PubMed ID: 19110631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Product-enhanced reverse transcriptase assay for replication-competent retrovirus and lentivirus detection.
    Sastry L; Xu Y; Duffy L; Koop S; Jasti A; Roehl H; Jolly D; Cornetta K
    Hum Gene Ther; 2005 Oct; 16(10):1227-36. PubMed ID: 16218784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors.
    McKay T; Patel M; Pickles RJ; Johnson LG; Olsen JC
    Gene Ther; 2006 Apr; 13(8):715-24. PubMed ID: 16397505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel trans-lentiviral vector that affords predictable safety.
    Wu X; Wakefield JK; Liu H; Xiao H; Kralovics R; Prchal JT; Kappes JC
    Mol Ther; 2000 Jul; 2(1):47-55. PubMed ID: 10899827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo evaluation of an EIAV vector for the systemic genetic delivery of therapeutic antibodies.
    Lamikanra A; Myers KA; Ferris N; Mitrophanous KA; Carroll MW
    Gene Ther; 2005 Jun; 12(12):988-98. PubMed ID: 15772687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High efficiency retroviral vectors that contain no viral coding sequences.
    Yu SS; Kim JM; Kim S
    Gene Ther; 2000 May; 7(9):797-804. PubMed ID: 10822307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a retroviral vector production system with the minimum possibility of a homologous recombination.
    Yu SS; Han E; Hong Y; Lee JT; Kim S; Kim S
    Gene Ther; 2003 Apr; 10(8):706-11. PubMed ID: 12692599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and in vivo characterization of self-inactivating human and non-human lentiviral expression vectors engineered for streptogramin-adjustable transgene expression.
    Mitta B; Weber CC; Rimann M; Fussenegger M
    Nucleic Acids Res; 2004 Jul; 32(12):e106. PubMed ID: 15258250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and mutational analysis of the reverse transcriptase of the lentivirus equine infectious anemia virus.
    Shaharabany M; Rice NR; Hizi A
    Biochem Biophys Res Commun; 1993 Oct; 196(2):914-20. PubMed ID: 7694581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of HIV-1 and EIAV-based lentiviral vectors in corneal transduction.
    Beutelspacher SC; Ardjomand N; Tan PH; Patton GS; Larkin DF; George AJ; McClure MO
    Exp Eye Res; 2005 Jun; 80(6):787-94. PubMed ID: 15939034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable and efficient intraocular gene transfer using pseudotyped EIAV lentiviral vectors.
    Balaggan KS; Binley K; Esapa M; Iqball S; Askham Z; Kan O; Tschernutter M; Bainbridge JW; Naylor S; Ali RR
    J Gene Med; 2006 Mar; 8(3):275-85. PubMed ID: 16299834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safe two-plasmid production for the first clinical lentivirus vector that achieves >99% transduction in primary cells using a one-step protocol.
    Lu X; Humeau L; Slepushkin V; Binder G; Yu Q; Slepushkina T; Chen Z; Merling R; Davis B; Chang YN; Dropulic B
    J Gene Med; 2004 Sep; 6(9):963-73. PubMed ID: 15352069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.